Skip to main content

Peer Review reports

From: Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review

Original Submission
22 Nov 2017 Submitted Original manuscript
4 Dec 2017 Author responded Author comments - Philippe ROCHIGNEUX
Resubmission - Version 2
4 Dec 2017 Submitted Manuscript version 2
8 Jun 2018 Reviewed Reviewer Report - Ulka Vaishampayan
21 Jun 2018 Reviewed Reviewer Report - Cristina Rodriguez-Antona
26 Jun 2018 Reviewed Reviewer Report - Andrew S Protheroe
24 Oct 2018 Author responded Author comments - Philippe ROCHIGNEUX
Resubmission - Version 3
24 Oct 2018 Submitted Manuscript version 3
25 Oct 2018 Reviewed Reviewer Report - Cristina Rodriguez-Antona
25 Oct 2018 Reviewed Reviewer Report - Ulka Vaishampayan
2 Nov 2018 Reviewed Reviewer Report - Andrew S Protheroe
4 Nov 2018 Author responded Author comments - Philippe ROCHIGNEUX
Resubmission - Version 4
4 Nov 2018 Submitted Manuscript version 4
Publishing
6 Nov 2018 Editorially accepted
22 Nov 2018 Article published 10.1186/s12885-018-5049-3

You can find further information about peer review here.

Back to article page